United States - English - NLM (National Library of Medicine)

bionpharma inc. - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron hydrochloride tablets are indicated for the prevention of: - nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. - nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hydrochloride is contraindicated in patients with known hypersensitivity to the drug or any of its components.

Kenya - English - Pharmacy and Poisons Board

tasa pharma ltd kay complex, unit c1-c3 kay complex, mombasa rd, - granisetron - solution for injection - 1 mg/ml - granisetron

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

aft pharmaceuticals (se asia) sdn bhd - granisetron hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - granisetron hydrochloride -

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - granisetron - concentrate for soln for inf - 3 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - granisetron - concentrate for soln for inf - 1 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - granisetron - concentrate for soln for inf - 1 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag - granisetron hydrochloride granisetron - solution for injection - 1 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - granisetron hydrochloride - film coated tablet - 2 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - granisetron hydrochloride - film coated tablet - 1 milligram